Edit |   |
---|---|
Antigenic Specificity | B-lymphocyte surface antigen B1 (Imvotamab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgM kappa |
Format | Protein A purified |
Size | 100 µg, 1 mg, |
Concentration | 1 mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Imvotamab is a Chimeric Humanized monoclonal antibody targeting B-lymphocyte surface antigen B1, expressed in Mammalian cells. |
Immunogen | n/a |
Other Names | Imvotamab, decavalent, monovalent, bispecific, B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain |
Gene, Accession # | UniProt: P11836, P07766 |
Catalog # | abx831796 |
Price | please inquire |
Order / More Info | B-lymphocyte surface antigen B1 (Imvotamab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950